Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 95

1.

Bleeding due to acquired dysfibrinogenemia as the initial presentation of multiple myeloma.

Siddiq N, Bergstrom C, Anderson LD Jr, Nagalla S.

BMJ Case Rep. 2019 Jul 17;12(7). pii: e229312. doi: 10.1136/bcr-2019-229312.

PMID:
31320370
2.

Coagulation Testing in Patients Taking Direct Oral Anticoagulants: A Teachable Moment.

Siddiq N, Nagalla S, Choi SH.

JAMA Intern Med. 2019 Jun 24. doi: 10.1001/jamainternmed.2019.1799. [Epub ahead of print] No abstract available.

PMID:
31233085
3.

AAIM Guidelines for Interview and Post-Interview Communication for Graduate Medical Education Recruitment.

Alweis RL, Williams CM, Luther VP, Simmons DL, Kopelman R, Angus SV, Liao S, Nagalla S, Muchmore EA.

Am J Med. 2019 Sep;132(9):1106-1111. doi: 10.1016/j.amjmed.2019.05.023. Epub 2019 Jun 6. No abstract available.

PMID:
31175844
4.

Role of Platelet Transfusion in the Reversal of Anti-Platelet Therapy.

Nagalla S, Sarode R.

Transfus Med Rev. 2019 Apr;33(2):92-97. doi: 10.1016/j.tmrv.2019.01.002. Epub 2019 Jan 25. Review.

PMID:
30814031
5.

The Direct Antiglobulin Test for Evaluating Anemia.

Eule C, Gupta A, Nagalla S.

JAMA. 2018 Dec 25;320(24):2593-2594. doi: 10.1001/jama.2018.14317. No abstract available.

PMID:
30508030
6.

Drugs for preventing red blood cell dehydration in people with sickle cell disease.

Nagalla S, Ballas SK.

Cochrane Database Syst Rev. 2018 Oct 19;10:CD003426. doi: 10.1002/14651858.CD003426.pub6.

PMID:
30338520
7.

What's in a name? The heterogeneous clinical spectrum and prognostic factors in a cohort of adults with hemophagocytic lymphohistiocytosis.

Prokesch BC, Nagalla S, Ezzati F, Tujios SR, Dominguez A, Chen W, Kershaw C, Patel P, de la Flor C, Foster J, Martin AA, de la Morena MT, Wysocki CA.

Transfus Apher Sci. 2018 Dec;57(6):779-784. doi: 10.1016/j.transci.2018.10.001. Epub 2018 Oct 6.

PMID:
30327177
8.

Intravenous immunoglobulin as an adjunct therapy in persisting heparin-induced thrombocytopenia.

Park BD, Kumar M, Nagalla S, De Simone N, Aster RH, Padmanabhan A, Sarode R, Rambally S.

Transfus Apher Sci. 2018 Aug;57(4):561-565. doi: 10.1016/j.transci.2018.06.007. Epub 2018 Jun 26. Review.

9.

Acute Kidney Injury Due to Concomitant Vancomycin and Piperacillin-Tazobactam-Reply.

Bergstrom C, Nagalla S, Gupta A.

JAMA Intern Med. 2018 Aug 1;178(8):1137-1138. doi: 10.1001/jamainternmed.2018.2921. No abstract available.

PMID:
30083742
10.

Hypercoagulable Workup in Thrombotic Cardiovascular Diseases.

Shen YM, Nagalla S.

Circulation. 2018 Jul 17;138(3):229-231. doi: 10.1161/CIRCULATIONAHA.117.031699. No abstract available.

PMID:
30012700
11.

A Mediastinal Mass in a Young Man.

Jain S, Gupta A, Nagalla S.

JAMA. 2018 Jun 19;319(23):2432-2433. doi: 10.1001/jama.2018.7107. No abstract available.

PMID:
29922807
12.

Management of Patients With Febrile Neutropenia: A Teachable Moment.

Bergstrom C, Nagalla S, Gupta A.

JAMA Intern Med. 2018 Apr 1;178(4):558-559. doi: 10.1001/jamainternmed.2017.8386. No abstract available.

PMID:
29435575
13.

Recent advances in understanding and management of acquired thrombocytopenia.

Nagalla S, Sarode R.

F1000Res. 2018 Jan 17;7:68. doi: 10.12688/f1000research.12309.1. eCollection 2018. Review.

14.

Antiphospholipid Antibodies.

Gupta A, Johnson DH, Nagalla S.

JAMA. 2017 Sep 12;318(10):959-960. doi: 10.1001/jama.2017.4854. No abstract available.

PMID:
28898362
15.

Thyroid storm and warm autoimmune hemolytic anemia.

Moore JA, Gliga L, Nagalla S.

Transfus Apher Sci. 2017 Aug;56(4):606-608. doi: 10.1016/j.transci.2017.08.003. Epub 2017 Aug 18.

PMID:
28870408
16.

Thrombophilia Testing in Provoked Venous Thromboembolism: A Teachable Moment.

Gupta A, Sarode R, Nagalla S.

JAMA Intern Med. 2017 Aug 1;177(8):1195-1196. doi: 10.1001/jamainternmed.2017.1815. No abstract available.

PMID:
28586816
17.

Re: Bleeding Risk and Management in Interventional Procedures in Chronic Liver Disease.

Sarode R, Agrawal D, Cripps M, Kalva SP, Nagalla S.

J Vasc Interv Radiol. 2017 Jun;28(6):921-922. doi: 10.1016/j.jvir.2017.02.021. No abstract available.

PMID:
28532751
18.

Complement inhibition with eculizumab for thrombotic microangiopathy rescues a living-donor kidney transplant in a patient with antiphospholipid antibody syndrome.

Geethakumari PR, Mille P, Gulati R, Nagalla S.

Transfus Apher Sci. 2017 Jun;56(3):400-403. doi: 10.1016/j.transci.2017.02.007. Epub 2017 Mar 10.

PMID:
28428030
19.

Effect of Vorapaxar Alone and in Combination with Aspirin on Bleeding Time and Platelet Aggregation in Healthy Adult Subjects.

Kraft WK, Gilmartin JH, Chappell DL, Gheyas F, Walker BM, Nagalla S, Naik UP, Horrow JC, Wrishko RE, Zhang S, Anderson MS.

Clin Transl Sci. 2016 Aug;9(4):221-7. doi: 10.1111/cts.12405. Epub 2016 Jun 15.

20.

Reversibility of Apixaban Anticoagulation with a Four-Factor Prothrombin Complex Concentrate in Healthy Volunteers.

Nagalla S, Thomson L, Oppong Y, Bachman B, Chervoneva I, Kraft WK.

Clin Transl Sci. 2016 Jun;9(3):176-80. doi: 10.1111/cts.12398. Epub 2016 May 12.

21.

Drugs for preventing red blood cell dehydration in people with sickle cell disease.

Nagalla S, Ballas SK.

Cochrane Database Syst Rev. 2016 Mar 4;3:CD003426. doi: 10.1002/14651858.CD003426.pub5. Review. Update in: Cochrane Database Syst Rev. 2018 Oct 19;10:CD003426.

PMID:
26942338
22.

Personalized medicine in thrombosis: back to the future.

Nagalla S, Bray PF.

Blood. 2016 Jun 2;127(22):2665-71. doi: 10.1182/blood-2015-11-634832. Epub 2016 Feb 4. Review.

23.

"The Immune Conundrum": Acquired Hemophilia A, Immune Thrombocytopenia, and Neutropenia in a Patient with Pancreatic Cancer.

Geethakumari PR, Sama A, Caro JG, Yeo CJ, Nagalla S.

Case Rep Pancreat Cancer. 2016 Jan 1;2(1):14-18. doi: 10.1089/crpc.2015.29011.prg. eCollection 2016.

24.

Angiotensin-converting enzyme (ACE) inhibitors for proteinuria and microalbuminuria in people with sickle cell disease.

Sasongko TH, Nagalla S, Ballas SK.

Cochrane Database Syst Rev. 2015 Jun 4;(6):CD009191. doi: 10.1002/14651858.CD009191.pub3. Review.

25.

Maternal serum biomarkers for risk assessment in gestational diabetes. A potential universal screening test to predict GDM status.

Nagalla SR, Snyder CK, Michaels JE, Laughlin MJ, Roberts CT, Balaji M, Balaji V, Seshiah V, Rao PV.

Indian J Endocrinol Metab. 2015 Jan-Feb;19(1):155-9. doi: 10.4103/2230-8210.140226.

26.

Dual roles for immune metagenes in breast cancer prognosis and therapy prediction.

Alistar A, Chou JW, Nagalla S, Black MA, D'Agostino R Jr, Miller LD.

Genome Med. 2014 Oct 28;6(10):80. doi: 10.1186/s13073-014-0080-8. eCollection 2014.

27.

Salivary protein glycosylation as a noninvasive biomarker for assessment of glycemia.

Rao PV, Laurie A, Bean ES, Roberts CT Jr, Nagalla SR.

J Diabetes Sci Technol. 2015 Jan;9(1):97-104. doi: 10.1177/1932296814554414. Epub 2014 Oct 10.

28.

Maternal serum glycosylated fibronectin as a point-of-care biomarker for assessment of preeclampsia.

Rasanen J, Quinn MJ, Laurie A, Bean E, Roberts CT Jr, Nagalla SR, Gravett MG.

Am J Obstet Gynecol. 2015 Jan;212(1):82.e1-9. doi: 10.1016/j.ajog.2014.07.052. Epub 2014 Jul 31.

PMID:
25086276
29.

Human platelet microRNA-mRNA networks associated with age and gender revealed by integrated plateletomics.

Simon LM, Edelstein LC, Nagalla S, Woodley AB, Chen ES, Kong X, Ma L, Fortina P, Kunapuli S, Holinstat M, McKenzie SE, Dong JF, Shaw CA, Bray PF.

Blood. 2014 Apr 17;123(16):e37-45. doi: 10.1182/blood-2013-12-544692. Epub 2014 Feb 12.

30.

Racial differences in human platelet PAR4 reactivity reflect expression of PCTP and miR-376c.

Edelstein LC, Simon LM, Montoya RT, Holinstat M, Chen ES, Bergeron A, Kong X, Nagalla S, Mohandas N, Cohen DE, Dong JF, Shaw C, Bray PF.

Nat Med. 2013 Dec;19(12):1609-16. doi: 10.1038/nm.3385. Epub 2013 Nov 10.

31.

Proteomic analysis of cervical vaginal fluid proteins among women in recurrent preterm labor.

Lo JO, Reddy AP, Wilmarth PA, Roberts VH, Kinhnarath A, Snyder J, Rincon MP, Gravett MG, Nagalla SR, Pereira LM.

J Matern Fetal Neonatal Med. 2014 Aug;27(12):1183-8. doi: 10.3109/14767058.2013.852172. Epub 2013 Nov 7.

PMID:
24102235
32.

Glycosylated fibronectin as a first-trimester biomarker for prediction of gestational diabetes.

Rasanen JP, Snyder CK, Rao PV, Mihalache R, Heinonen S, Gravett MG, Roberts CT Jr, Nagalla SR.

Obstet Gynecol. 2013 Sep;122(3):586-94. doi: 10.1097/AOG.0b013e3182a0c88b.

PMID:
23921871
33.

Oncologic management of hereditary colorectal cancer.

Yacoub G, Nagalla S, Aklilu M.

Clin Colon Rectal Surg. 2012 Jun;25(2):118-22. doi: 10.1055/s-0032-1313783.

34.

Interactions between immunity, proliferation and molecular subtype in breast cancer prognosis.

Nagalla S, Chou JW, Willingham MC, Ruiz J, Vaughn JP, Dubey P, Lash TL, Hamilton-Dutoit SJ, Bergh J, Sotiriou C, Black MA, Miller LD.

Genome Biol. 2013 Apr 29;14(4):R34. doi: 10.1186/gb-2013-14-4-r34.

35.

Angiotensin-converting enzyme (ACE) inhibitors for proteinuria and microalbuminuria in people with sickle cell disease.

Sasongko TH, Nagalla S, Ballas SK.

Cochrane Database Syst Rev. 2013 Mar 28;(3):CD009191. doi: 10.1002/14651858.CD009191.pub2. Review. Update in: Cochrane Database Syst Rev. 2015;(6):CD009191.

PMID:
23543572
36.

The complex transcriptional landscape of the anucleate human platelet.

Bray PF, McKenzie SE, Edelstein LC, Nagalla S, Delgrosso K, Ertel A, Kupper J, Jing Y, Londin E, Loher P, Chen HW, Fortina P, Rigoutsos I.

BMC Genomics. 2013 Jan 16;14:1. doi: 10.1186/1471-2164-14-1.

37.

Drugs for preventing red blood cell dehydration in people with sickle cell disease.

Nagalla S, Ballas SK.

Cochrane Database Syst Rev. 2012 Jul 11;(7):CD003426. doi: 10.1002/14651858.CD003426.pub4. Review. Update in: Cochrane Database Syst Rev. 2016;3:CD003426.

PMID:
22786485
38.

Human genome-wide association and mouse knockout approaches identify platelet supervillin as an inhibitor of thrombus formation under shear stress.

Edelstein LC, Luna EJ, Gibson IB, Bray M, Jin Y, Kondkar A, Nagalla S, Hadjout-Rabi N, Smith TC, Covarrubias D, Jones SN, Ahmad F, Stolla M, Kong X, Fang Z, Bergmeier W, Shaw C, Leal SM, Bray PF.

Circulation. 2012 Jun 5;125(22):2762-71. doi: 10.1161/CIRCULATIONAHA.112.091462. Epub 2012 May 1.

39.

Transfection of human platelets with short interfering RNA.

Hong W, Kondkar AA, Nagalla S, Bergmeier W, Jin Y, Herman JH, Bray PF.

Clin Transl Sci. 2011 Jun;4(3):180-2. doi: 10.1111/j.1752-8062.2011.00279.x.

40.

Excessive ovarian production of nerve growth factor elicits granulosa cell apoptosis by setting in motion a tumor necrosis factor α/stathmin-mediated death signaling pathway.

Garcia-Rudaz C, Dorfman M, Nagalla S, Svechnikov K, Söder O, Ojeda SR, Dissen GA.

Reproduction. 2011 Aug;142(2):319-31. doi: 10.1530/REP-11-0134. Epub 2011 Jun 6.

41.

Platelet microRNA-mRNA coexpression profiles correlate with platelet reactivity.

Nagalla S, Shaw C, Kong X, Kondkar AA, Edelstein LC, Ma L, Chen J, McKnight GS, López JA, Yang L, Jin Y, Bray MS, Leal SM, Dong JF, Bray PF.

Blood. 2011 May 12;117(19):5189-97. doi: 10.1182/blood-2010-09-299719. Epub 2011 Mar 17.

42.

Expression of kinesin superfamily genes in cultured hippocampal neurons.

Silverman MA, Kaech S, Ramser EM, Lu X, Lasarev MR, Nagalla S, Banker G.

Cytoskeleton (Hoboken). 2010 Dec;67(12):784-95. doi: 10.1002/cm.20487. Epub 2010 Nov 2.

43.

Comprehensive maternal serum proteomic profiles of preclinical and clinical preeclampsia.

Rasanen J, Girsen A, Lu X, Lapidus JA, Standley M, Reddy A, Dasari S, Thomas A, Jacob T, Pouta A, Surcel HM, Tolosa JE, Gravett MG, Nagalla SR.

J Proteome Res. 2010 Aug 6;9(8):4274-81. doi: 10.1021/pr100198m.

PMID:
20568817
44.

Noninvasive diagnosis of intraamniotic infection: proteomic biomarkers in vaginal fluid.

Hitti J, Lapidus JA, Lu X, Reddy AP, Jacob T, Dasari S, Eschenbach DA, Gravett MG, Nagalla SR.

Am J Obstet Gynecol. 2010 Jul;203(1):32.e1-8. doi: 10.1016/j.ajog.2010.03.037. Epub 2010 May 15.

45.

Insights into the multifactorial nature of preterm birth: proteomic profiling of the maternal serum glycoproteome and maternal serum peptidome among women in preterm labor.

Pereira L, Reddy AP, Alexander AL, Lu X, Lapidus JA, Gravett MG, Nagalla SR.

Am J Obstet Gynecol. 2010 Jun;202(6):555.e1-10. doi: 10.1016/j.ajog.2010.02.048. Epub 2010 Apr 21. Erratum in: Am J Obstet Gynecol. 2011 Jan;204(1):86.

PMID:
20413102
46.

Drugs for preventing red blood cell dehydration in people with sickle cell disease.

Nagalla S, Ballas SK.

Cochrane Database Syst Rev. 2010 Jan 20;(1):CD003426. doi: 10.1002/14651858.CD003426.pub3. Review. Update in: Cochrane Database Syst Rev. 2012;7:CD003426.

PMID:
20091545
47.

Platelet RNA chips dip into thrombocytosis.

Nagalla S, Bray PF.

Blood. 2010 Jan 7;115(1):2-3. doi: 10.1182/blood-2009-10-246405. No abstract available.

PMID:
20056796
48.

VAMP8/endobrevin is overexpressed in hyperreactive human platelets: suggested role for platelet microRNA.

Kondkar AA, Bray MS, Leal SM, Nagalla S, Liu DJ, Jin Y, Dong JF, Ren Q, Whiteheart SW, Shaw C, Bray PF.

J Thromb Haemost. 2010 Feb;8(2):369-78. doi: 10.1111/j.1538-7836.2009.03700.x. Epub 2009 Nov 23.

49.

Quantification of isotopically overlapping deamidated and 18o-labeled peptides using isotopic envelope mixture modeling.

Dasari S, Wilmarth PA, Reddy AP, Robertson LJ, Nagalla SR, David LL.

J Proteome Res. 2009 Mar;8(3):1263-70. doi: 10.1021/pr801054w.

50.

Proteomic identification of salivary biomarkers of type-2 diabetes.

Rao PV, Reddy AP, Lu X, Dasari S, Krishnaprasad A, Biggs E, Roberts CT, Nagalla SR.

J Proteome Res. 2009 Jan;8(1):239-45. doi: 10.1021/pr8003776.

PMID:
19118452

Supplemental Content

Loading ...
Support Center